Dental Membrane and Bone Graft Substitute Market

The global Dental Membrane and Bone Graft Substitute Market is valued at USD 1.2 Billion in 2023 and is projected to reach a value of USD 2.2 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 7.1% between 2024 and 2032 driven by the growing incidence of dental issues, such as periodontal diseases, tooth loss, and bone degeneration, is driving the demand for dental membranes and bone graft substitutes to support effective treatment and regeneration.

Key Highlights

• By Product type, the Bone Graft Substitutes segment accounted for the highest market share of 62.1% in 2023
• Based on the Material Type, the Hydrogel category accounted for 17.2% of the market share in 2023
• In 2023, by Application, Socket Preservation dominated the market with market share of 32.5%
• North America dominated the market with 41.1% market share in 2023
• The increasing popularity of dental implants for cosmetic purpose is fueling the demand for dental membranes and bone graft substitutes

Major objectives of Dental Membrane and Bone Graft Substitute Market Study

• To gain a comprehensive understanding of the Dental Membrane and Bone Graft Substitute market by identifying its key segments and subsegments
• To provide an in-depth analysis of the factors driving or hindering market growth, including emerging opportunities and challenges specific to the industry
• To analyze individual market segments for growth trends, future prospects, and their impact on the overall market
• To explore potential opportunities for stakeholders in the Dental Membrane and Bone Graft Substitute market and to map out the competitive landscape of leading players
• To profile major companies within the market, evaluating their market share, strengths, and competitive advantages

Product Overview

​The Product segment is divided into Dental Membrane and Bone Graft Substitutes. The Bone Graft Substitutes segment held the dominant share in 2023, accounting for 62.1% share.

Bone graft substitutes have become compelling alternatives to traditional bone grafts by offering a solution to replace lost or damaged bone while avoiding the complications associated with autografts and allografts. These substitutes, including allogenic bone matrix, synthetic bone grafts, and bone morphogenetic proteins, can be easily shaped and stabilized at the defect site, and they release key factors that stimulate bone regeneration. Particularly, synthetic bone grafts made of beta-tricalcium phosphate and hydroxyapatite are increasingly replacing traditional graft materials due to their superior osteoconductive properties. Research is also focusing on developing substitutes with antibacterial properties to reduce the risk of surgical site infections, as well as biomimetic options that closely replicate the natural bone microenvironment. With continuous technological advancements, bone graft substitutes are poised to transform orthopedic repair and reconstruction practices worldwide.

Application Overview

The Application segment is divided into Ridge Augmentation, Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration, Socket Preservation. In 2023, the Socket Preservation segment held a 32.5% share in the Dental Membrane and Bone Graft Substitute market.

The socket preservation plays vital function in preserving the alveolar bone structure following tooth extraction, which is necessary for the proper implantation of dental implants. The extensive usage of socket preservation techniques in dental treatments and their significant market presence are both attributed to their ability to prevent bone resorption and maintain ideal conditions for future implants. The increasing number of dental implant treatments and the general public's growing awareness of oral health care are driving the socket preservation.

Regional Overview

In 2023, the Europe, captured 41.1% of the revenue share.

Europe has a well-established dental infrastructure, with countries like Germany, the U.K., and France leading in advanced dental procedures and technologies. The high concentration of dental experts and large investments in R&D indicates strong market presence. In the field of dental biomaterial research, European universities are also at the forefront, encouraging regional innovation and product development. European dental enterprises hold a substantial market share, which further strengthened by their innovative products and many top dental companies. Furthermore, there is a growing need for efficient dental membranes and bone graft alternatives throughout Europe due to the rising incidence of dental conditions such periodontal diseases and tooth loss. For instance, according to the state of oral health, over 50% of the European population may experience some form of periodontitis, with more than 10% suffering from severe cases. The prevalence of the disease rises significantly with age, affecting 70-85% of individuals between 60 and 65 years old.

The Asia Pacific region is emerging as the fastest-growing market for dental membranes and bone graft substitutes, driven by rapid economic development and an increasing middle-class population. Countries like China and India are witnessing heightened dental tourism due to cost-effective dental treatments and a growing awareness of advanced dental care options. The increasing prevalence of oral diseases and a rise in dental implant surgeries are expected to fuel market growth. Local manufacturing facilities established by global players serve the vast patient demographics, amplifying the region's market potential.

North America represents a significant portion of the Dental Membrane and Bone Graft Substitute market, particularly the United States. Factors such as a robust healthcare infrastructure, high dental spending, and a strong focus on specialized dental care contribute to this market presence. With over 200,000 dental practitioners in the U.S., the market is characterized by a demand for advanced treatment modalities, including bone grafting procedures and regenerative therapies. Supportive reimbursement policies also facilitate patient access to these innovative dental solutions, ensuring a steady pipeline of procedures using dental membranes and graft substitutes.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Advancements in Biomaterials: Increasing development and adoption of advanced biomaterials, including synthetic and bioactive substances, are enhancing the performance and efficacy of dental membranes and bone graft substitutes
• Rising Demand for Minimally Invasive Procedures: There is a growing preference for minimally invasive dental procedures, which drives the demand for advanced bone graft substitutes and membranes that facilitate quicker recovery and reduced surgical trauma
• Integration of Digital Technologies: The integration of digital technologies such as 3D printing, CAD/CAM systems, and digital imaging is improving the customization and precision of dental implants and grafts, enhancing treatment outcomes and patient satisfaction
• Increased Focus on Regenerative Medicine: The emphasis on regenerative medicine and tissue engineering is fueling innovations in dental membranes and bone graft substitutes, aiming to achieve better bone growth, integration, and functionality

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Definition

​Dental membranes and bone graft substitutes are crucial in periodontal tissue regeneration and dental implant placements.​ These products facilitate the healing process by providing a scaffold for new bone growth and preventing soft tissues from interfering with bone regeneration. Their effectiveness has increased adoption in various surgical applications, significantly enhancing patient clinical outcomes.

Market Dynamics

Growing incidence of dental disorders

The growing incidence of dental disorders, such as periodontal diseases and tooth loss, is a major factor fueling the demand for dental membranes and bone graft substitutes. For instance, according to World Health Organization report, oral diseases impact nearly 3.5 billion people globally.

Increased Utilization of Bone Grafts in Dentistry

The expanding application of bone grafts in dental procedures is significantly driving the global market for dental membranes and bone graft substitutes. In procedures, such as dental implants, tooth extractions, facial trauma care, and reconstructive surgeries involving the mouth, face, and jaws, these grafts are crucial for supporting bone growth and regeneration.

High Costs of Bone Graft Surgeries

The elevated cost associated with bone graft surgeries, particularly autografts, limits their use to only minor bone abnormalities. Increased surgical risks associated with these operations include excessive bleeding, infection, inflammation, and discomfort for the patient. As of 2023, global bone transplant surgeries were estimated to cost approximately USD 664 million, with about 2.2 million procedures projected annually. The number of surgeries for bone abnormalities is expected to grow by nearly 13% each year.

Competitive Landscape

The competitive landscape of the Dental Membrane and Bone Graft Substitute market is characterized by a diverse array of key players and emerging companies, each vying for market share through innovative product offerings and strategic partnerships. Major companies in the field are leveraging advanced technologies, such as synthetic and biologically derived materials, to enhance the efficacy and safety of their products. Competitive strategies include mergers and acquisitions, collaborations for technological advancements, and expanding product portfolios to address various clinical needs. The market is also influenced by ongoing research and development activities aimed at improving the performance and patient outcomes of dental membranes and bone graft substitutes, driving competition among established and new entrants alike.

The key players in the global Dental Membrane and Bone Graft Substitute market include - Dentsply Sirona Inc., Sunstar Suisse S.A., ACE Surgical Supply Company Inc., Olympus Terumo Biomaterials Corp, BioHorizons IPH Inc., Citagenix, Medtronic plc, NovaBone Products LLC, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., DDS Lab, RTI Surgical Holdings Inc., Dentium, Institut Straumann AG, Kuraray Co. Ltd., LifeNet Health, BEGO Medical GmbH, Collagen Matrix Inc., Danaher Corporation, Straumann Holding AG among others.

Recent Market Developments

ZimVie Inc. Launches Biotivity A/C Plus Membrane to Enhance Dental Reconstruction and Implant Support

• In October 2023, ZimVie Inc., a leading global life sciences company, introduced the Biotivity A/C Plus Membrane in the U.S. This innovative barrier membrane, enriched with growth factors, is designed for dental applications to assist in jaw reconstruction and support dental implants. The launch marks a significant expansion of ZimVie's footprint in the dental biomaterials sector, with an emphasis on improving wound healing

Biocomposites Partners with Zimmer Biomet for Genex Bone Graft Substitute Distribution

• In March 2022, Biocomposites entered into a distribution agreement with Zimmer Biomet for the new Genex Bone Graft Substitute. This biphasic composite, known for its exceptional purity, is specifically designed to balance the strength of an osteoconductive scaffold with its persistence in the body, facilitating the optimal remodeling of bone architecture

CGBio Secures KRW 10 Billion Export Deal with Kerunxi Medical for Bongros Dental

• In March 2022, CGbio signed a five-year contract valued at KRW 10 billion with Kerunxi Medical, a Chinese company specializing in dental equipment, for the export of Bongros Dental, a bone graft material

Orthofix Medical Partners with CGBio to Advance Novosis™ Bone Growth Materials in North America

• In August 2022, Orthofix Medical Inc., a global leader in spine and orthopedic medical devices, announced a strategic partnership with CGBio, a developer of innovative synthetic bone grafts widely used in Asia for spine, orthopedic, trauma, and dental applications. This collaboration focuses on advancing the clinical development and commercialization of Novosis™ recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials, along with other future tissue regenerative solutions, in the U.S. and Canadian markets

The global Dental Membrane and Bone Graft Substitute market can be categorized as Product Type, Material Type, Application, End Use and Region.